Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease

scientific article

Disturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1016/S0736-5748(01)00007-7
P698PubMed publication ID11337192

P2093author name stringArendt T
P2860cites workPhosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neuronsQ22010952
ERKs: a family of protein-serine/threonine kinases that are activated and tyrosine phosphorylated in response to insulin and NGFQ24304344
cPLA2 is phosphorylated and activated by MAP kinaseQ24314148
Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4Q24314643
p15INK4B is a potential effector of TGF-beta-induced cell cycle arrestQ24319021
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Q24322196
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4aQ24324559
Long-lasting potentiation of synaptic transmission in the dentate area of the anaesthetized rabbit following stimulation of the perforant pathQ24538964
Long-lasting potentiation of synaptic transmission in the dentate area of the unanaestetized rabbit following stimulation of the perforant pathQ24538966
Nuclear localization and regulation of erk- and rsk-encoded protein kinasesQ24606980
STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylationQ24644334
Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6Q24652510
Navigation-related structural change in the hippocampi of taxi driversQ24679349
Neuropathological stageing of Alzheimer-related changesQ27860862
Conversion of p35 to p25 deregulates Cdk5 activity and promotes neurodegenerationQ28140796
A cell cycle regulator potentially involved in genesis of many tumor typesQ28251933
Neurogenesis in the adult human hippocampusQ28288339
Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinomaQ28300339
Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentQ29547294
Inhibitors of mammalian G1 cyclin-dependent kinasesQ29547907
Running increases cell proliferation and neurogenesis in the adult mouse dentate gyrusQ29615348
Intercorrelations of regional cerebral glucose metabolic rates in Alzheimer's disease.Q53193376
A quantitative morphometric analysis of the neuronal and synaptic content of the frontal and temporal cortex in patients with Alzheimer's disease.Q53193790
Growth of abnormal neurites in atypical Alzheimer's disease. A study with the Golgi method.Q53198364
Increased expression and subcellular translocation of the mitogen activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease.Q53199479
Insulin-like growth factors and insulin-like growth factor binding proteins in cerebrospinal fluid and serum of patients with dementia of the Alzheimer typeQ53201609
Correlation of cytokine secretion by mononuclear cells of Alzheimer patients and their disease stage.Q53205622
Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21ras and p16INK4a.Q53232860
Immunoreactive epidermal growth factor receptors in neuritic plaques from patients with Alzheimer's disease.Q53303541
Platelet membrane fluidity individuals at risk for Alzheimer's disease: a comparison of results from fluorescence spectroscopy and electron spin resonance spectroscopy.Q53336899
Neuronal apoptosis is associated with a decrease in tau mRNA expression.Q54137147
p42 map kinase phosphorylation sites in microtubule-associated protein tau are dephosphorylated by protein phosphatase 2A1Implications for Alzheimer's diseaseQ55920639
Structural and Functional Analysis of a Mutant Ras Protein That Is Insensitive to Nitric Oxide Activation†Q57976106
Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascadeQ58112395
Effects of apolipoprotein E genotype on blood lipid composition and membrane platelet fluidity in Alzheimer’s diseaseQ58793678
Amplification of calcium-induced gene transcription by nitric oxide in neuronal cellsQ59054217
Neuronal growth cone collapse and inhibition of protein fatty acylation by nitric oxideQ59071954
NCAM Is Essential for Axonal Growth and Fasciculation in the HippocampusQ63433211
Computer-assisted morphometry of synaptic plasticity during aging and dementiaQ69449760
Monoclonal antibody to embryonic CNS antigen A2B5 provides evidence for the involvement of membrane components at sites of Alzheimer degeneration and detects sulfatides as well as gangliosidesQ69522766
Axotomy-induced apoptotic cell death of neonatal rat facial motoneurons: time course analysis and relation to NADPH-diaphorase activityQ70983734
Paired helical filament-like phosphorylation of tau, deposition of beta/A4-amyloid and memory impairment in rat induced by chronic inhibition of phosphatase 1 and 2AQ70989967
Nitric oxide delays the death of trophic factor-deprived PC12 cells and sympathetic neurons by a cGMP-mediated mechanismQ71001959
Differential activation of mitogen-activated protein kinases by nitric oxide-related speciesQ71245891
Expression of a phosphorylated isoform of MAP1B is maintained in adult central nervous system areas that retain capacity for structural plasticityQ71306801
Ras p21 protein promotes survival and differentiation of human embryonic neural crest-derived cellsQ71538962
Loss of synaptophysin-like immunoreactivity in the hippocampal formation is an early phenomenon in Alzheimer's diseaseQ72119373
Ki-67 immunoreactivity in Alzheimer's disease and other neurodegenerative disordersQ72224719
Analysis of cell cycle-related gene expression in postmitotic neurons: selective induction of Cyclin D1 during programmed cell deathQ72247935
A molecular redox switch on p21(ras). Structural basis for the nitric oxide-p21(ras) interactionQ73039100
Induction of the cyclin-dependent kinase inhibitor p21(Sdi1/Cip1/Waf1) by nitric oxide-generating vasodilator in vascular smooth muscle cellsQ73201827
Neural cell adhesion molecule-stimulated neurite outgrowth depends on activation of protein kinase C and the Ras-mitogen-activated protein kinase pathwayQ73514875
A novel, nerve growth factor-activated pathway involving nitric oxide, p53, and p21WAF1 regulates neuronal differentiation of PC12 cellsQ73692291
Ras-signaling pathways: positive and negative regulation of tau expression in PC12 cellsQ74015471
Age-dependent deterioration of neuronal mambranes and the pathogenesis of Alzheimer's disease: A hypothesisQ41436662
Structural correlates of cognition in dementia: quantification and assessment of synapse change.Q41443879
Microtubule-associated protein tau is hyperphosphorylated during mitosis in the human neuroblastoma cell line SH-SY5Y.Q41478097
Neuronal loss in different parts of the nucleus basalis is related to neuritic plaque formation in cortical target areas in Alzheimer's diseaseQ41495612
An insulin-stimulated protein kinase similar to yeast kinases involved in cell cycle controlQ41728250
From biophysics to models of network functionQ41733261
Synaptic loss in Alzheimer's disease and other dementiasQ41984306
STUDIES ON THE COMPARATIVE ANATOMY OF THE GANGLION BASALE OF MEYNERTQ42449165
Perisomatic sprouts immunoreactive for nerve growth factor receptor and neurofibrillary degeneration affect different neuronal populations in the basal nucleus in patients with Alzheimer's diseaseQ42450383
Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's DiseaseQ42460226
Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. II. Ageing, Korsakoff's disease, Parkinson's disease, and Alzheimer's diseaseQ42477274
Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. I. Dendritic organisation of the normal human basal forebrainQ42484194
Dendritic reorganisation in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areasQ42484200
Microtubular reorganization and dendritic growth response in Alzheimer's diseaseQ42500791
Amyloid deposition in the nucleus basalis of Meynert complex: a topographic marker for degenerating cell clusters in Alzheimer's diseaseQ42518088
Dendritic changes in the basal nucleus of Meynert and in the diagonal band nucleus in Alzheimer's disease--a quantitative Golgi investigationQ42526716
Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein epsilon 4 alleleQ42528671
Structural characterization of the tumor suppressor p16, an ankyrin-like repeat proteinQ42845500
ras p21 protein promotes survival and fiber outgrowth of cultured embryonic neuronsQ43456719
Maintenance of Neuronal Plasticity in the Reticular Core and Changes in Trophic Activity in Alzheimer's DiseaseQ43561519
Basic fibroblast growth factor in Alzheimer's diseaseQ43819151
Laminar and regional distributions of neurofibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory corticesQ44032224
Interaction of bride of sevenless membrane-bound ligand and the sevenless tyrosine-kinase receptorQ44292632
PDGF is associated with neuronal and glial alterations of Alzheimer's diseaseQ44368985
Quantitative assessment of cortical synaptic density in Alzheimer's disease.Q44558369
Structural plasticity of synapses in Alzheimer's diseaseQ44566695
Aberrant localization of MAP5 immunoreactivity in the hippocampal formation in Alzheimer's diseaseQ45013971
Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injuryQ45080981
Increase of c-fos and ras oncoproteins in the denervated neuropil of the rat dentate gyrusQ45089570
Alzheimer's disease and Down syndrome: leukocyte membrane fluidity alterationsQ45104380
Patterns of aberrant sprouting in Alzheimer's diseaseQ45166469
Identification and distribution of axonal dystrophic neurites in Alzheimer's disease.Q45934715
Topographical distribution of synaptic-associated proteins in the neuritic plaques of Alzheimer's disease hippocampus.Q45971272
Increased expression of the embryonic form of a developmentally regulated mRNA in Alzheimer's diseaseQ46061836
Differing patterns of aberrant neuronal sprouting in Alzheimer's disease with and without Lewy bodiesQ46193510
Mechanisms of synaptic pathology in Alzheimer's disease.Q46292748
Increased expression of cyclin D1 in the adult rat brain following kainic acid treatment.Q46558994
Immunohistochemical quantification of the synapse-related protein synaptophysin in Alzheimer diseaseQ46715401
Synaptic and neuritic alterations during the progression of Alzheimer's diseaseQ46842058
Induction of basic Fibroblast Growth Factor in Alzheimerʼs disease pathologyQ46894345
Encephalization in hominids: evidence for the model of punctuationalismQ47583681
Brefeldin A-induced apoptosis is expressed in rat neurons with dephosphorylated tau protein.Q47719985
Cell cycle-related protein expression in vascular dementia and Alzheimer's diseaseQ48122211
Interaction foci, information synthesis, and mental activityQ48133798
Cortical load of PHF-tau in Alzheimer's disease is correlated to cholinergic dysfunctionQ48139341
Nitric oxide synthase in motor neurons after axotomyQ48153760
Membrane lipids, selectively diminished in Alzheimer brains, suggest synapse loss as a primary event in early-onset form (type I) and demyelination in late-onset form (type II).Q48164740
Plasticity in the organization of adult cerebral cortical maps: a computer simulation based on neuronal group selection.Q48172674
Loss of proteins regulating synaptic plasticity in normal aging of the human brain and in Alzheimer diseaseQ48183012
Axonal disruption and aberrant localization of tau protein characterize the neuropil pathology of Alzheimer's diseaseQ48189763
Hippocampal plasticity in Alzheimer's disease: changes in highly polysialylated NCAM immunoreactivity in the hippocampal formationQ48228415
Senile plaques as aberrant sprout-stimulating structuresQ48269555
Detection of NGF-like activity in human brain tissue: increased levels in Alzheimer's diseaseQ48270749
Molecular markers of reactive plasticityQ37782779
Axon sprouting in the rodent and Alzheimer's disease brain: a reactivation of developmental mechanisms?Q37949876
Na+/H+ exchange and growth factor-induced cytosolic pH changes. Role in cellular proliferationQ38263958
Behaviorally based modeling and computational approaches to neuroscienceQ38565652
Assessing some dynamic properties of the living nervous system.Q38771394
Effects of growth factors on intracellular pH regulationQ39501675
The brain as a self-organizing systemQ39741104
Cell adhesion molecules in the regulation of animal form and tissue patternQ39760631
Synapse replacement in the nervous system of adult vertebratesQ40310185
Cell cycle-dependent phosphorylation and microtubule binding of tau protein stably transfected into Chinese hamster ovary cells.Q40367128
Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control.Q40384078
Protein phosphorylation in neuronal plasticity and gene expressionQ40425911
Surface modulation in cell recognition and cell growthQ40490719
The role of interleukin-6 in certain age-related diseasesQ40578463
Psychiatry and the new dynamicsQ40661475
Gases as biological messengers: nitric oxide and carbon monoxide in the brainQ40701647
Hyperactivation of signal transduction systems in Alzheimer's diseaseQ40779667
Synaptic pathology of Alzheimer's diseaseQ40779683
Distribution and possible roles of the highly polysialylated neural cell adhesion molecule (NCAM-H) in the developing and adult central nervous systemQ40792461
The role of synaptic proteins in the pathogenesis of disorders of the central nervous systemQ40794820
The synaptic organization of the neocortex in Alzheimer's diseaseQ40805034
Cell death and the cell cycle: a relationship between transformation and neurodegeneration?Q40823834
Mitotic phosphoepitopes precede paired helical filaments in Alzheimer's diseaseQ40843729
Dendritic sprouting in Alzheimer's presenile dementiaQ40898751
The central adaptation syndrome: psychosocial stress as a trigger for adaptive modifications of brain structure and brain functionQ40943697
Inhibitors of cyclin-dependent kinase and cancerQ40958606
Cyclin D1 is an essential mediator of apoptotic neuronal cell death.Q41063498
Mechanisms and molecules that control growth cone guidanceQ41132678
Immunoelectron microscopic study of synaptic pathology in Alzheimer's diseaseQ41162802
A possible fetal antigen of Mr 70,000 in neurofibrillary tanglesQ41168795
Prenatal development of NADPH-diaphorase-reactive neurons in human frontal cortexQ41169681
Cyclin D1 expression is regulated positively by the p42/p44MAPK and negatively by the p38/HOGMAPK pathway.Q41173912
Nerve growth factor and ras regulate beta-amyloid precursor protein gene expression in PC12 cellsQ41190133
Increased immunoreactivity of brain spectrin in Alzheimer disease: a marker for synapse loss?Q41221217
Immunochemical evidence that fragments of phosphorylated MAP5 (MAP1B) are bound to neurofibrillary tangles in Alzheimer's diseaseQ41233680
Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionQ41335802
Modifiable neuronal connections: an overview for psychiatristsQ41336617
Nitric oxide triggers a switch to growth arrest during differentiation of neuronal cellsQ41347334
Nitric oxide-stimulated guanine nucleotide exchange on p21rasQ41357997
Signaling through focal adhesion kinaseQ41359146
Activation of Raf as a result of recruitment to the plasma membraneQ29618481
pp125FAK in the focal adhesion.Q30468927
Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathwaysQ30470153
The microtubule-associated protein MAP1B is involved in local stabilization of turning growth conesQ30836998
Localization of amyloid precursor protein in GAP43-immunoreactive aberrant sprouting neurites in Alzheimer's diseaseQ30991317
Synaptic pathology in Alzheimer's disease: immunological data for markers of synaptic and large dense-core vesicles.Q30991642
Molecular mechanisms that underlie structural and functional changes at the postsynaptic membrane during synaptic plasticityQ32052477
Abnormal brain spectrin immunoreactivity in sprouting neurons in Alzheimer diseaseQ33410853
Elevated expression of p21ras is an early event in Alzheimer's disease and precedes neurofibrillary degenerationQ33640174
Reexpression of a developmentally regulated antigen in Down syndrome and Alzheimer diseaseQ33642172
Neuro-regeneration: plasticity for repair and adaptationQ33733439
In vivo PET imaging and postmortem studies suggest potentially reversible and irreversible stages of brain metabolic failure in Alzheimer's diseaseQ33827620
Effect of cell spreading on cytoplasmic pH in normal and transformed fibroblastsQ33862274
Mitogen-activated Swiss mouse 3T3 RSK kinases I and II are related to pp44mpk from sea star oocytes and participate in the regulation of pp90rsk activityQ34119239
Activated mitogenic signaling induces a process of dedifferentiation in Alzheimer's disease that eventually results in cell death.Q34148259
The Reorganization of Somatosensory Cortex Following Peripheral Nerve Damage in Adult and Developing MammalsQ34256277
14-3-3: modulators of signaling proteins?Q34324416
A cdc2-related kinase PSSALRE/cdk5 is homologous with the 30 kDa subunit of tau protein kinase II, a proline-directed protein kinase associated with microtubuleQ34345777
Phosphoprotein phosphatase activities in Alzheimer disease brainQ34356873
Fetal-type phosphorylation of the tau in paired helical filamentsQ34377013
Cortical plasticity: from synapses to mapsQ34462829
Structure of the Ki-ras gene of the human lung carcinoma cell line Calu-1.Q34708404
Phosphorylation of c-jun mediated by MAP kinases.Q34947174
Mitogen-activated protein kinases: versatile transducers for cell signalingQ35231791
MorphoregulationQ35251037
Secreted beta-amyloid precursor protein stimulates mitogen-activated protein kinase and enhances tau phosphorylation.Q35616076
Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21rasQ36099162
A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycleQ36235418
Mitotic mechanisms in Alzheimer's disease?Q36236501
The abnormal phosphorylation of tau protein at Ser-202 in Alzheimer disease recapitulates phosphorylation during developmentQ36335067
Dendritic Growth in the Aged Human Brain and Failure of Growth in Senile DementiaQ36537341
Cortical neurons express nerve growth factor receptors in advanced age and Alzheimer diseaseQ36787954
Growth-regulated proteins and neuronal plasticity. A commentaryQ37071575
Neuroscience, modularity and personality theory: conceptual foundations of a model of complex human functioningQ37711345
Abnormal tau phosphorylation at Ser396 in Alzheimer's disease recapitulates development and contributes to reduced microtubule bindingQ48277664
Neuronal maturation and synaptogenesis in the rat ventrobasal complex: alignment with developmental changes in rate and severity of axon reactionQ48285307
Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathwaysQ48291009
Regulation of neuronal plasticity in the central nervous system by phosphorylation and dephosphorylationQ48306227
Neuronal expression of cycline dependent kinase inhibitors of the INK4 family in Alzheimer's diseaseQ48320192
Stress and the adaptive self-organization of neuronal connectivity during early childhoodQ48368841
Alzheimer plaques and cortical cholinergic innervationQ48387944
Glycogen synthase kinase-3 and the Alzheimer-like state of microtubule-associated protein tau.Q48394153
Plasticity of hippocampal circuitry in Alzheimer's diseaseQ48428006
Changes in acetylcholinesterase and butyrylcholinesterase in Alzheimer's disease resemble embryonic development--a study of molecular formsQ48429301
Implication of brain cdc2 and MAP2 kinases in the phosphorylation of tau protein in Alzheimer's diseaseQ48444661
Mapping of the distribution of polysialylated neural cell adhesion molecule throughout the central nervous system of the adult rat: an immunohistochemical studyQ48462155
Phosphorylation of tau, Abeta-formation, and apoptosis after in vivo inhibition of PP-1 and PP-2A.Q48482683
Ectopic cell cycle proteins predict the sites of neuronal cell death in Alzheimer's disease brain.Q48487273
Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodelling in the adult brainQ48510341
Hepatocyte growth factor (HGF/SF) in Alzheimer's diseaseQ48528548
Apoptosis-related protein expression in the hippocampus in Alzheimer's diseaseQ48537871
On areas of transition between entorhinal allocortex and temporal isocortex in the human brain. Normal morphology and lamina-specific pathology in Alzheimer's diseaseQ48538921
Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathwayQ48567917
Tau proteins of Alzheimer paired helical filaments: abnormal phosphorylation of all six brain isoformsQ48571996
Insulin-like growth factor-I (IGF-I) immunoreactivity in the Alzheimer's disease temporal cortex and hippocampusQ48591069
Cell cycle markers in the hippocampus in Alzheimer's diseaseQ48671520
Aberrant expression of mitotic cdc2/cyclin B1 kinase in degenerating neurons of Alzheimer's disease brainQ48706959
Cultured neurons expressing phosphorylated tau are more resistant to apoptosis induced by NMDA or serum deprivationQ48747792
Expression of cell division markers in the hippocampus in Alzheimer's disease and other neurodegenerative conditionsQ48786969
Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal regionQ48795521
EM study of the numbers of cortical synapses in the brains of ageing people and people with Alzheimer-type dementiaQ48822024
Alzheimer's disease neurofibrillary tangles contain mitosis-specific phosphoepitopes.Q48856816
Trk receptor alterations in Alzheimer's disease.Q48880171
Neuronal plasticity and astrocytic reaction in Down syndrome and Alzheimer diseaseQ48929987
PSA-NCAM is required for activity-induced synaptic plasticity.Q48934025
Neuronal alterations in patients with dementia: a Golgi study on biopsy samplesQ48949924
Development of Alzheimer-related neurofibrillary changes in the neocortex inversely recapitulates cortical myelogenesisQ48952395
A high ratio of chromogranin A to synaptin/synaptophysin is a common feature of brains in Alzheimer and Pick diseaseQ49018185
Epidermal growth factor receptor expression in demented and aged human brainQ49023304
Brain function, synapse renewal, and plasticityQ49112231
Observations on the evolution of the cholinergic system in the telencephalon of vertebratesQ49124328
Prospective study of risk factors for Alzheimer's disease: results at 7.5 yearsQ50539819
The contribution of altered synapses in the senile plaque: an electron microscopic study in Alzheimer's dementiaQ51221560
LTP promotes formation of multiple spine synapses between a single axon terminal and a dendrite.Q52030569
Neuronal-based synaptic compensation: a computational study in Alzheimer's disease.Q52046759
Dendritic degeneration and regrowth in the cerebral cortex of patients with Alzheimer's disease.Q52105175
Dendritic extent in human dentate gyrus granule cells in normal aging and senile dementia.Q52132943
Oncogenesis and altered differentiation induced by activated Ras in neuroblasts of transgenic mice.Q52191569
Nitric oxide regulates cell proliferation during Drosophila development.Q52551520
The binding of basic fibroblast growth factor to Alzheimer's neurofibrillary tangles and senile plaquesQ53181497
Massive somatodendritic sprouting of cortical neurons in Alzheimer's disease.Q53191496
P433issue3
P921main subjectpathogenesisQ372016
neuroplasticityQ849491
P304page(s)231-245
P577publication date2001-06-01
P1433published inInternational Journal of Developmental NeuroscienceQ6051371
P1476titleDisturbance of neuronal plasticity is a critical pathogenetic event in Alzheimer's disease
P478volume19

Reverse relations

cites work (P2860)
Q48943001A case for a non-transgenic animal model of Alzheimer's disease
Q28265282APOE genotype effects on Alzheimer's disease onset and epidemiology
Q35968110Alcohol Elicits Functional and Structural Plasticity Selectively in Dopamine D1 Receptor-Expressing Neurons of the Dorsomedial Striatum.
Q48219142Alterations of synaptic turnover rate in aging may trigger senile plaque formation and neurodegeneration
Q30341746ApoE-dependent plasticity in Alzheimer's disease.
Q37060457Apolipoprotein E and Alzheimer's disease: molecular mechanisms and therapeutic opportunities.
Q37310717Apolipoprotein E epsilon4 magnifies lifestyle risks for dementia: a population-based study
Q33337322Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.
Q38420841Axonal tract tracing for delineating interacting brain regions: implications for Alzheimer's disease-associated memory
Q54738945Cell cycle activation and CNS injury.
Q44210278Changes in activity and expression of phosphofructokinase in different rat brain regions after basal forebrain cholinergic lesion
Q48405944Connective tissue growth factor in Alzheimer's disease
Q51757214Cytometry in the brain: studying differentiation to diagnostic applications in brain disease and regeneration therapy.
Q47711160Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype
Q38109214Developmental neuroplasticity and the origin of neurodegenerative diseases
Q33835741Diabetes induces changes in ILK, PINCH and components of related pathways in the spinal cord of rats
Q36003859Does beta-amyloid plaque formation cause structural injury to neuronal processes?
Q34771671Functional recovery of cholinergic basal forebrain neurons under disease conditions: old problems, new solutions?
Q46595342Fyn kinase modulates synaptotoxicity, but not aberrant sprouting, in human amyloid precursor protein transgenic mice.
Q44697181GAP-43 mRNA detection by in situ hybridization, direct and indirect in situ RT-PCR in hippocampal and cerebellar tissue sections of adult rat brain
Q34053056Genetic connections between neurological disorders and cholesterol metabolism
Q37026050Loss of presenilin function is associated with a selective gain of APP function.
Q37138837Multiple effects of β-amyloid on single excitatory synaptic connections in the PFC.
Q48889735Neuronal plasticity and degeneration
Q34976296Neuroplasticity in Alzheimer's disease
Q35194715Pin1 promotes degradation of Smad proteins and their interaction with phosphorylated tau in Alzheimer's disease
Q37184490Polymorphism of brain derived neurotrophic factor influences β amyloid load in cognitively intact apolipoprotein E ε4 carriers
Q37691024Proteomic Analysis of Mitochondria-Enriched Fraction Isolated from the Frontal Cortex and Hippocampus of Apolipoprotein E Knockout Mice Treated with Alda-1, an Activator of Mitochondrial Aldehyde Dehydrogenase (ALDH2)
Q33494148Redox proteomic analysis of carbonylated brain proteins in mild cognitive impairment and early Alzheimer's disease
Q42485051Reduced spine density in specific regions of CA1 pyramidal neurons in two transgenic mouse models of Alzheimer's disease.
Q28202553Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory
Q24535750Specific inhibition of CBP/beta-catenin interaction rescues defects in neuronal differentiation caused by a presenilin-1 mutation
Q36782611Synaptic and mitochondrial morphometry provides structural correlates of successful brain aging
Q24675772Synaptic plasticity in animal models of early Alzheimer's disease
Q27004724Tangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing Problem
Q38036916Targeting synaptic dysfunction in Alzheimer's disease therapy.
Q35170198What can rodent models tell us about cognitive decline in Alzheimer's disease?

Search more.